ESAS was founded to join European forces with regard to psychotic disorders and thus contribute to the European Research Area.
Schizophrenia still poses many unsolved questions to researchers and every day challenges to clinicians. Therefore ESAS was founded in autumn 2011 on occasion of the 3rd European Conference on Schizophrenia in Berlin in order to encourage and promote Europe-wide scientific exchange and scientific study projects on schizophrenia and to broadly provide current information on schizophrenia, also to the public. Thus ESAS is meant to
- strengthen the European schizophrenia research community,
- enhance the international visibility of this part of the “European Research Area”,
- deal with specific European issues in schizophrenia research and treatment (e.g. harmonisation of quality assurance measures like treatment guidelines),
- bring together resources and expertise from a number of research institutes in different countries to tackle scientific questions that are key to the advancement in the field,
- initiate, encourage and promote Europe-wide scientific exchange and scientific study projects on schizophrenia,
- provide current information on schizophrenia.
ESAS will do this by organizing meetings (congresses, seminars, workshops), initiating and managing all kinds of collaborative research including basic, clinical and mental health services related issues, developing as well as offering training and educational programmes, lobbying for destigmatization of schizophrenia and for schizophrenia research and providing mental health education and consultation to the broad public.